1200005I advanced bioscience laboratories, INC;manufacture and characterization services for vaccines
Ended Awarded Last action
- Contract number
- HHSN27200007
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $784,847
Award facts
- Contract value 100% obligated
- $784,847.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$34,283 | |
| Other Administrative Action | -$49,620 | |
| Funding Only Action | $15,621 | |
| Funding Only Action | $40,000 | |
| Exercise an Option | $143,055 | |
| Exercise an Option | $137,529 | |
| Exercise an Option | $132,341 | |
| Original award | $415,825 |
About this award
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL) for $784,847.21. The contract is for the manufacture and characterization of vaccines. ABL is a foreign-owned, for-profit manufacturer of goods that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The contract does not have a set-aside designation, reflecting ABL's status as a large business in the federal contracting landscape. ABL has been awarded numerous federal contracts and grants, particularly from NIAID and HHS, to advance the development of medical countermeasures for various infectious diseases and other health conditions. This contract is part of ABL's broader work supporting preclinical and clinical development programs for the government, which includes cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management.
Quick answers
Who was awarded contract HHSN27200007?
HHSN27200007 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 6, 2014.
How much is contract HHSN27200007 worth?
The government has obligated $784,847 on HHSN27200007.
Is contract HHSN27200007 an order under another contract?
Yes. HHSN27200007 is a delivery order under HHSN272201200005I, an indefinite delivery contract.
Was contract HHSN27200007 competed?
The extent of competition for HHSN27200007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award